Richard Law Score: 27
Analyst at
Goldman Sachs,
Credit Suisse
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-7.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
40%
6 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
54%
7 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
15%
2 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 13 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
5 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
46%
6 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 |
Bicara Therapeutics Inc. Common Stock
BCAX
|
SELL |
$14.00
Est. +5%
|
$14.80 | $13.80 (Low) |
Precision Hit (±3%)
|
$23.23
-57.0%
|
| Jan 12, 2026 |
Arcus Biosciences Inc
RCUS
|
BUY |
$28.00
Est. +31%
|
$21.30 | $28.72 |
Precision Hit (±3%)
|
$24.31
+14.1%
|
| Jan 12, 2026 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$67.00
Est. +26%
|
$53.25 | $56.99 |
Pending
|
$35.87
-32.6%
|
| Oct 30, 2025 |
Arcutis Biotherapeutics Inc
ARQT
|
BUY |
$29.00
Est. +14%
|
$25.41 | $31.77 |
Target Met
|
$26.21
+3.1%
|
| Jul 10, 2025 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$36.00
Est. +13%
|
$31.99 | $57.99 |
Target Met
|
$35.87
+12.1%
|
| May 28, 2025 |
Rocket Pharmaceuticals Inc
RCKT
|
SELL |
$2.00
Est. +19%
|
$2.48 | $2.35 (Low) |
Miss
|
$3.35
-35.1%
|
| Nov 21, 2024 |
Merus N.V
MRUS
|
BUY |
$73.00
Est. +44%
|
$50.74 | $96.30 |
Target Met
|
$90.00
+77.4%
|
| Oct 24, 2024 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$27.00
Est. +127%
|
$11.91 | $13.51 |
Miss
|
$9.51
-20.2%
|
| Aug 14, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$25.00
Est. +76%
|
$14.18 | $27.20 |
Target Met
|
$16.63
+17.3%
|
| Jun 06, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$23.00
Est. +273%
|
$6.17 | $27.20 |
Target Met
|
$16.63
+169.5%
|
| Apr 02, 2024 |
Olema Pharmaceuticals Inc
OLMA
|
BUY |
$24.00
Est. +120%
|
$10.89 | $16.62 |
Miss
|
$9.51
-12.7%
|
| Apr 02, 2024 |
MoonLake Immunotherapeutics - Ordinary Shares - Class A
MLTX
|
BUY |
$62.00
Est. +28%
|
$48.60 | $58.26 |
Miss
|
$19.21
-60.5%
|
| Apr 02, 2024 |
Mineralys Therapeutics Inc
MLYS
|
BUY |
$30.00
Est. +130%
|
$13.03 | $18.37 |
Miss
|
$24.63
+89.0%
|
| Apr 02, 2024 |
Rocket Pharmaceuticals Inc
RCKT
|
BUY |
$39.00
Est. +46%
|
$26.72 | $26.98 |
Miss
|
$3.35
-87.5%
|
| Dec 06, 2022 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$32.00
Est. +10%
|
$29.11 | - | - |
$90.43
+210.6%
|
Bicara Therapeutics Inc. Common Stock
BCAX
Feb 11, 2026
Signal & Target
SELL
$14.00
Start Price
$14.80
Best Price (1Y)
$13.80
Current Price
$23.23
Return
-57.0%
Arcus Biosciences Inc
RCUS
Jan 12, 2026
Signal & Target
BUY
$28.00
Start Price
$21.30
Best Price (1Y)
$28.72
Current Price
$24.31
Return
+14.1%
Crinetics Pharmaceuticals Inc
CRNX
Jan 12, 2026
Signal & Target
BUY
$67.00
Start Price
$53.25
Best Price (1Y)
$56.99
Current Price
$35.87
Return
-32.6%
Arcutis Biotherapeutics Inc
ARQT
Oct 30, 2025
Signal & Target
BUY
$29.00
Start Price
$25.41
Best Price (1Y)
$31.77
Current Price
$26.21
Return
+3.1%
Crinetics Pharmaceuticals Inc
CRNX
Jul 10, 2025
Signal & Target
BUY
$36.00
Start Price
$31.99
Best Price (1Y)
$57.99
Current Price
$35.87
Return
+12.1%
Rocket Pharmaceuticals Inc
RCKT
May 28, 2025
Signal & Target
SELL
$2.00
Start Price
$2.48
Best Price (1Y)
$2.35
Current Price
$3.35
Return
-35.1%
Merus N.V
MRUS
Nov 21, 2024
Signal & Target
BUY
$73.00
Start Price
$50.74
Best Price (1Y)
$96.30
Current Price
$90.00
Return
+77.4%
Olema Pharmaceuticals Inc
OLMA
Oct 24, 2024
Signal & Target
BUY
$27.00
Start Price
$11.91
Best Price (1Y)
$13.51
Current Price
$9.51
Return
-20.2%
Viridian Therapeutics Inc
VRDN
Aug 14, 2024
Signal & Target
BUY
$25.00
Start Price
$14.18
Best Price (1Y)
$27.20
Current Price
$16.63
Return
+17.3%
Viridian Therapeutics Inc
VRDN
Jun 06, 2024
Signal & Target
BUY
$23.00
Start Price
$6.17
Best Price (1Y)
$27.20
Current Price
$16.63
Return
+169.5%
Olema Pharmaceuticals Inc
OLMA
Apr 02, 2024
Signal & Target
BUY
$24.00
Start Price
$10.89
Best Price (1Y)
$16.62
Current Price
$9.51
Return
-12.7%
Signal & Target
BUY
$62.00
Start Price
$48.60
Best Price (1Y)
$58.26
Current Price
$19.21
Return
-60.5%
Mineralys Therapeutics Inc
MLYS
Apr 02, 2024
Signal & Target
BUY
$30.00
Start Price
$13.03
Best Price (1Y)
$18.37
Current Price
$24.63
Return
+89.0%
Rocket Pharmaceuticals Inc
RCKT
Apr 02, 2024
Signal & Target
BUY
$39.00
Start Price
$26.72
Best Price (1Y)
$26.98
Current Price
$3.35
Return
-87.5%
Kymera Therapeutics Inc
KYMR
Dec 06, 2022
Signal & Target
BUY
$32.00
Start Price
$29.11
Best Price (1Y)
-
Current Price
$90.43
Return
+210.6%